The classic website will no longer be available as of June 25, 2024. Please use the modernized
Working… Menu

Clinical Trial of GAIA-102 for Refractory/Relapse Neuroblastomas and Other Malignant Pediatric Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT05608148
Recruitment Status : Recruiting
First Posted : November 8, 2022
Last Update Posted : March 28, 2024
Information provided by (Responsible Party):
Kyushu University

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : August 25, 2027
Estimated Study Completion Date : August 25, 2027